18F-FDG and 11C-choline uptake in proliferating tumor cells is dependent on the cell cycle in vitro

被引:11
作者
Roppongi, Motoi [1 ]
Izumisawa, Mitsuru [1 ]
Terasaki, Kazunori [2 ]
Muraki, Yasushi [3 ]
Shozushima, Masanori [1 ]
机构
[1] Iwate Med Univ, Sch Dent, Div Dent Radiol, 1-3-27 Chuodori, Morioka, Iwate 0208505, Japan
[2] Iwate Med Univ, Cyclotron Res Ctr, 348-58 Tomegamori, Takizawa, Iwate 0200603, Japan
[3] Iwate Med Univ, Sch Med, Dept Microbiol, Div Infect Dis & Immunol, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan
关键词
F-18-FDG; C-11-choline; Cell cycle; FUNCTIONAL-CHARACTERIZATION; CHOLINE TRANSPORTER; CANCER-CELLS; FDG-PET; SYNCHRONIZATION; FLUORINE-18-FLUORODEOXYGLUCOSE; MACROPHAGES; METABOLISM; EXPRESSION; CARCINOMA;
D O I
10.1007/s12149-018-01325-6
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective Among different PET tracers, F-18-fludeoxyglucose (FDG) and C-11-choline are known to have a high tumor uptake correlated with a high mitotic index of tumor cells. Thus, the uptake of F-18-FDG and C-11-choline may be dependent on the cell cycle. In the present study, we examined the uptake of F-18-FDG and C-11-choline in cancer cell lines by cell cycle synchronization to clarify the biological properties of cancer cells with respect to each tracer. Methods HeLa S3 Cells were synchronized by the double thymidine (TdR) block methods. F-18-FDG and C-11-choline were administered to synchronized cells, and the radioactivity per cell was measured to compare the cellular uptake of the tracers during S, G2/M, and G1 phases. Flow cytometry (FCM) was performed to measure the proportion of cells in G1, S, and G2/M phases. Furthermore, the levels of glucose transporter 1 (GLUT1) and choline transporter-like protein 1 (CTL1) in the cell were evaluated by FCM. Results The uptake of F-18-FDG was the highest in S to G2/M phases, and markedly decreased in G1 phase. The uptake of C-11-choline reached its peak in G2/M, and decreased in G1 phase. The level of GLUT1 expression was similar to that of F-18-FDG uptake during the cell cycle, and the level of CTL1 expression was similar to that of C-11-choline uptake throughout the cell cycle. Conclusions In this in vitro study, we demonstrated that F-18-FDG and C-11-choline had the highest uptake in S to G2/M phases and in G2/M phase, respectively, with a rapid decrease in G1 phase. These findings suggest that F-18-FDG and C-11-choline have a high accumulation in tumor cells with a high mitotic index. Furthermore, our study suggests that the expression of GLUT1 and CTL1 has cell cycle dependence, and the changes of F-18-FDG and C-11-choline accumulation seem to be caused by the above properties of these transporters.
引用
收藏
页码:237 / 243
页数:7
相关论文
共 50 条
  • [31] Metabolites of 18F-FDG and 3-O-11C-methylglucose in pig liver
    Bender, D
    Munk, OL
    Feng, HQ
    Keiding, S
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (11) : 1673 - 1678
  • [32] 18F-FDG /18F-Choline Dual-Tracer PET Behavior and Tumor Differentiation in HepatoCellular Carcinoma. A Systematic Review
    Ghidaglia, Jerome
    Golse, Nicolas
    Pascale, Alina
    Sebagh, Mylene
    Besson, Florent L.
    FRONTIERS IN MEDICINE, 2022, 9
  • [33] Comparison of 11C-4DST and 18F-FDG PET/CT imaging for advanced renal cell carcinoma: preliminary study
    Minamimoto, Ryogo
    Nakaigawa, Noboru
    Nagashima, Yoji
    Toyohara, Jun
    Ueno, Daiki
    Namura, Kazuhiro
    Nakajima, Kazuhiko
    Yao, Masahiro
    Kubota, Kazuo
    ABDOMINAL RADIOLOGY, 2016, 41 (03) : 521 - 530
  • [34] Cancer-associated fibroblasts enhance tumor 18F-FDG uptake and contribute to the intratumor heterogeneity of PET-CT
    Shangguan, Chengfang
    Gan, Guifang
    Zhang, Jieying
    Wu, Jinliang
    Miao, Ying
    Zhang, Miao
    Li, Biao
    Mi, Jun
    THERANOSTICS, 2018, 8 (05): : 1376 - 1388
  • [35] Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinoma
    Nesteruk, Marta
    Lang, Stephanie
    Veit-Haibach, Patrick
    Studer, Gabriela
    Stieb, Sonja
    Glatz, Stefan
    Hemmatazad, Hossein
    Ikenberg, Kristian
    Huber, Gerhard
    Pruschy, Martin
    Guckenberger, Matthias
    Kloeck, Stephan
    Riesterer, Oliver
    RADIOTHERAPY AND ONCOLOGY, 2015, 117 (01) : 125 - 131
  • [36] Combination of circulating tumor cells and 18F-FDG PET/CT for precision diagnosis in patients with non-small cell lung cancer
    Sun, Momo
    Lu, Dongyan
    Li, Xiaoping
    Wang, Jin
    Zhang, Liang
    Yang, Pan
    Yang, Yang
    Shen, Jie
    CANCER MEDICINE, 2024, 13 (18):
  • [37] Preoperative Detection of Prostate Cancer: a Comparison With 11C-Choline PET, 18F-Fluorodeoxyglucose PET and MR Imaging
    Watanabe, Haruo
    Kanematsu, Masayuki
    Kondo, Hiroshi
    Kako, Nobuo
    Yamamoto, Naoki
    Yamada, Toru
    Goshima, Satoshi
    Hoshi, Hiroaki
    Bae, Kyongtae T.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2010, 31 (05) : 1151 - 1156
  • [38] 18F-FDG uptake on PET correlates with biological potential in early oral squamous cell carcinoma
    Yokobori, Yuki
    Toyoda, Minoru
    Sakakura, Koichi
    Kaira, Kyoichi
    Tsushima, Yoshito
    Chikamatsu, Kazuaki
    ACTA OTO-LARYNGOLOGICA, 2015, 135 (05) : 494 - 499
  • [39] The Relationship Between GLUT-1 and Vascular Endothelial Growth Factor Expression and 18F-FDG Uptake in Esophageal Squamous Cell Cancer Patients
    Kobayashi, Maiko
    Kaida, Hayato
    Kawahara, Akihiko
    Hattori, Satoshi
    Kurata, Seiji
    Hayakawa, Masanobu
    Hirose, Yasumitsu
    Uchida, Masafumi
    Kage, Masayoshi
    Fujita, Hiromasa
    Hayabuchi, Naofumi
    Ishibashi, Masatoshi
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (05) : 447 - 452
  • [40] Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer
    Cho, Arthur
    Hur, Jin
    Moon, Yong Wha
    Hong, Sae Rom
    Suh, Young Joo
    Kim, Yun Jung
    Im, Dong Jin
    Hong, Yoo Jin
    Lee, Hye-Jeong
    Kim, Young Jin
    Shim, Hyo Sup
    Lee, Jae Seok
    Kim, Joo-Hang
    Choi, Byoung Wook
    BMC CANCER, 2016, 16